Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs IBB✓SelectedUSD · IBBGSK vs IBB performance historyLatest closeAs of-2.71%09/08
Stock and ETF performance explorer

GSK vs IBB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+76.8%
IBB return
+122.6%
Excess return
-45.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioIBBExcessAlpha
1D-2.7%-2.2%-0.5%-1.8%
7D-4.2%-1.7%-2.5%-3.5%
30D-7.5%+4.9%-12.4%-9.3%
3M-3.3%+24.2%-27.5%-11.5%
6M-9.3%+23.8%-33.2%-16.9%
YTD+1.6%+23.0%-21.4%-6.7%
1Y+25.5%+46.2%-20.7%+7.6%
3Y+49.3%+64.8%-15.6%+21.4%
5Y+46.7%+20.9%+25.8%+32.4%
10Y+76.8%+121.6%-44.8%+22.4%
All+76.8%+122.6%-45.8%+22.4%

Cumulative growth

Daily Returns

Daily percentage return beside IBB.

Daily Out/Under-Performance

Portfolio return minus IBB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × IBB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded IBB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling